We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-14.27%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$123B
AUM Growth
-$24.7B
(-17%)
Cap. Flow
-$418M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
30.06%
Holding
304
New
10
Increased
88
Reduced
149
Closed
13
Avg Time Held
3.8
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$485M |
| 2 |
Hess
HES
|
+$460M |
| 3 |
Wells Fargo
WFC
|
+$356M |
| 4 |
Albemarle
ALB
|
+$291M |
| 5 |
Linde
LIN
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$468M |
| 2 |
Dell
DELL
|
+$283M |
| 3 |
Adobe
ADBE
|
+$261M |
| 4 |
Praxair Inc
PX
|
+$231M |
| 5 |
NetApp
NTAP
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 25.96% |
| 3 | Industrials | 15.66% |
| 4 | Financials | 9.32% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Hewlett Packard
HPE
$77.8B
| $1.22B | 0.99% |
92,338,885
-4,631,564
| -5% | -$69.4M |
2015 Q4
12 quarters
|
|
27
BioMarin Pharmaceuticals
BMRN
$10.8B
| $1.21B | 0.98% |
14,185,173
-23,312
| -0.2% | -$2.22M |
2013 Q2
22 quarters
|
|
28
Caterpillar
CAT
$338B
| $1.19B | 0.96% |
9,367,059
-24,730
| -0.3% | -$3.22M |
2013 Q2
22 quarters
|
|
29
Ericsson
ERIC
$34.8B
| $1.18B | 0.96% |
132,970,106
+229,000
| +0.2% | +$1.99M |
2013 Q2
22 quarters
|
|
30
Intel
INTC
$504B
| $1.16B | 0.94% |
24,619,897
+63,400
| +0.3% | +$2.97M |
2013 Q2
22 quarters
|
|
31
Thermo Fisher Scientific
TMO
$258B
| $1.12B | 0.91% |
5,020,946
+1,572
| +0% | +$369K |
2013 Q4
20 quarters
|
|
32
KLA
KLAC
$228B
| $1.1B | 0.89% |
122,376,610
-706,350
| -0.6% | -$6.58M |
2013 Q2
22 quarters
|
|
33
Carnival Corporation Ltd
CCL
$35.6B
| $1.09B | 0.88% |
22,129,357
+1,576,145
| +8% | +$90.3M |
2013 Q2
22 quarters
|
|
|
ABMD
34
DELISTED
Abiomed Inc
ABMD
| $1.05B | 0.85% |
3,230,240
-141,700
| -4% | -$49.2M |
2013 Q2
22 quarters
|
|
35
Ross Stores
ROST
$75B
| $1.03B | 0.84% |
12,422,311
-28,480
| -0.2% | -$2.58M |
2013 Q2
22 quarters
|
|
36
Cisco
CSCO
$433B
| $995M | 0.81% |
22,954,611
-2,664,275
| -10% | -$122M |
2013 Q2
22 quarters
|
|
37
Bristol-Myers Squibb
BMY
$124B
| $966M | 0.78% |
18,577,374
-329,320
| -2% | -$17.7M |
2017 Q1
7 quarters
|
|
38
Royal Caribbean
RCL
$74.9B
| $939M | 0.76% |
9,598,511
-73,900
| -0.8% | -$8.1M |
2013 Q2
22 quarters
|
|
39
Abbott
ABT
$181B
| $923M | 0.75% |
12,767,557
-1,334,653
| -9% | -$93.8M |
2013 Q2
22 quarters
|
|
|
40
Bank of America
BAC
$362B
| $878M | 0.71% |
35,645,761
+17,861,234
| +100% | +$485M |
2017 Q1
7 quarters
|
|
41
Intuit
INTU
$88.2B
| $853M | 0.69% |
4,333,166
-519,215
| -11% | -$108M |
2013 Q2
22 quarters
|
|
42
Whirlpool
WHR
$1.83B
| $828M | 0.67% |
7,749,980
+99,840
| +1% | +$11.3M |
2013 Q2
22 quarters
|
|
43
NVIDIA
NVDA
$5.25T
| $826M | 0.67% |
247,439,680
-27,626,920
| -10% | -$132M |
2013 Q2
22 quarters
|
|
|
SGEN
44
DELISTED
Seagen Inc. Common Stock
SGEN
| $801M | 0.65% |
14,135,200
-320,900
| -2% | -$20.1M |
2013 Q2
22 quarters
|
|
45
DELISTED
Splunk Inc
SPLK
| $783M | 0.63% |
7,471,350
+369,152
| +5% | +$37.3M |
2016 Q4
8 quarters
|
|
46
DELISTED
Discover Financial Services
DFS
| $760M | 0.62% |
12,886,896
+344,701
| +3% | +$23.8M |
2014 Q1
19 quarters
|
|
47
CarMax
KMX
$7.47B
| $757M | 0.61% |
12,068,628
-248,175
| -2% | -$16.4M |
2013 Q2
22 quarters
|
|
48
TJX Companies
TJX
$159B
| $725M | 0.59% |
16,198,348
-89,284
| -0.5% | -$4.51M |
2013 Q2
22 quarters
|
|
49
Deere & Co
DE
$175B
| $723M | 0.59% |
4,848,991
-215,831
| -4% | -$31.6M |
2013 Q2
22 quarters
|
|
50
Marsh
MRSH
$89B
| $712M | 0.58% |
8,928,775
-728,686
| -8% | -$60.8M |
2013 Q2
22 quarters
|
|
Similar funds
Primecap Management's Q4 2018 Portfolio in Review
As of Q4 2018, Primecap Management held 304 positions worth $123B, down 17% from $148B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2018 filing shows 10 new, 88 increased, 149 reduced and 13 closed positions. Its largest new stake was Linde: 1,431,369 shares worth $223M. The largest sale was Eli Lilly, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2018 buy was Linde: 1,431,369 shares worth $223M.
- Primecap Management added most to Bank of America in Q4 2018, an estimated $485M increase.
- Primecap Management's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $468M.
- Primecap Management fully exited Praxair Inc in Q4 2018, selling an estimated $231M.
- Primecap Management's ten largest holdings make up 30% of its $123B portfolio in Q4 2018.
- Primecap Management opened 10 new positions and closed 13 in Q4 2018.
- Primecap Management's portfolio value fell 17% quarter-over-quarter to $123B.
Based on Primecap Management's 13F filing for Q4 2018, filed 12 Feb 2019.